Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002023265-25-000006
Filing Date
2025-10-27
Accepted
2025-10-27 16:56:25
Documents
2
Period of Report
2025-10-25

Document Format Files

Seq Description Document Type Size
1 form3-10272025_081021.html 3  
1 form3-10272025_081021.xml 3 1684
2 ex24-10272025_081022.htm EX-24 5253
  Complete submission text file 0002023265-25-000006.txt   8468
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-839-4360
MapLight Therapeutics, Inc. (Issuer) CIK: 0001770069 (see all company filings)

EIN.: 832163243 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MAPLIGHT THERAPEUTICS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Trenkle James D. (Reporting) CIK: 0002023265 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42914 | Film No.: 251420492